FDA Recalls Common Heart Medication Over Possible Cancer Risk

supplements
Photo by Tossapol from Shutterstock

The Exact Product Details

If you take this medication, check your prescription bottle against the following information:

Drug name: Bisoprolol Fumarate and Hydrochlorothiazide Tablets, USP, 2.5 mg / 6.25 mg

  • Bottle size: 100-count, Rx Only
  • Lot number: GBHL24005A
  • Expiration date: 09/2026
  • Manufactured by: Unichem Laboratoris Ltd., Goa, India
  • Distributed by: Unichem Pharmaceuticals (USA), Inc., East Brunswick, NJ 08816
  • NDC number: 29300-187-01

If your bottle matches this lot number and manufacturer information, contact your pharmacist or doctor right away.

« 1 2 3 4 ... 8»
Facebook
Twitter
Telegram
Reddit

10 Responses

  1. What are the names of the medications. You’re not helping anyone when you don’t even listen the names of the medications

    1. The recall affects Bisoprolol Fumarate (2.5 mg) and Hydrochlorothiazide (6.25 mg) tablets — a combination medication commonly prescribed to treat high blood pressure. The affected product comes in 100-count bottles and was distributed throughout the United States and Puerto Rico.

    1. The recall affects Bisoprolol Fumarate (2.5 mg) and Hydrochlorothiazide (6.25 mg) tablets — a combination medication commonly prescribed to treat high blood pressure. The affected product comes in 100-count bottles and was distributed throughout the United States and Puerto Rico.

  2. The recall affects Bisoprolol Fumarate (2.5 mg) and Hydrochlorothiazide (6.25 mg) tablets — a combination medication commonly prescribed to treat high blood pressure. The affected product comes in 100-count bottles and was distributed throughout the United States and Puerto Rico.

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Posts